9-78248353-G-C
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2
The NM_001330691.3(CEP78):c.955G>C(p.Glu319Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 1,555,972 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E319E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001330691.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP78 | NM_001330691.3 | c.955G>C | p.Glu319Gln | missense_variant, splice_region_variant | 7/17 | ENST00000643273.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP78 | ENST00000643273.2 | c.955G>C | p.Glu319Gln | missense_variant, splice_region_variant | 7/17 | NM_001330691.3 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.00880 AC: 1338AN: 152114Hom.: 15 Cov.: 32
GnomAD3 exomes AF: 0.00216 AC: 537AN: 248466Hom.: 7 AF XY: 0.00164 AC XY: 221AN XY: 134822
GnomAD4 exome AF: 0.000932 AC: 1308AN: 1403740Hom.: 15 Cov.: 24 AF XY: 0.000809 AC XY: 568AN XY: 702118
GnomAD4 genome ? AF: 0.00887 AC: 1351AN: 152232Hom.: 16 Cov.: 32 AF XY: 0.00825 AC XY: 614AN XY: 74438
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.Glu319Gln in exon 7 of CEP78: This variant is not expected to have clinical si gnificance because it has been identified in 2.84% (263/9252) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs61730338). - |
Cone-rod dystrophy and hearing loss 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 03, 2022 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at